Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 20, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions
Diabetic RetinopathyNon-Proliferative Diabetic RetinopathyRemote Ischemic ConditioningDiabetes Mellitus, Type 2Randomized Controlled Trial
Interventions
DEVICE

Remote Ischemic Conditioning Device

Participants in this group will use a remote ischemic conditioning device that applies five cycles of 5-minute inflation at 200 mmHg followed by 5-minute deflation on both arms, twice daily, for at least five days per week over one year. The device is designed to enhance retinal oxygenation and reduce hypoxia-related damage.

DEVICE

Sham Remote Ischemic Conditioning Device

Participants in this group will use the same remote ischemic conditioning device set to an inflation pressure of 60 mmHg to simulate the treatment. This placebo intervention follows the same timing and cycle frequency as the active intervention group.

Trial Locations (2)

100730

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

NOT_YET_RECRUITING

Xuanwu Hospital, Beijing

All Listed Sponsors
collaborator

Xuanwu Hospital, Beijing

OTHER

lead

Xuxiang Zhang, MD

OTHER